Steriade, Alexandru T. https://orcid.org/0000-0003-0253-6725
Johari, Shirin
Sargarovschi, Nicoleta
Necula, Daniela
Tudose, Cornelia E.
Ionita, Diana
Bogdan, Miron A.
Bumbacea, Dragos
Article History
Received: 26 August 2018
Accepted: 9 July 2019
First Online: 18 July 2019
Ethics approval and consent to participate
: The study was approved by the local Ethics Committee of Elias University and Emergency Hospital (reference number: 5451/18), and all subjects signed the informed consent.
: Not applicable
: Financial competing interests:DB has received speaker or advisory board fees from Chiesi, GSK, Linde and Novartis, institutional research funds (clinical trials) from Bayer, Chiesi, and Sanofi and in-kind equipment for the institution from Gongora and Linde.MAB has received speaker and advisory board fees from Chiesi, Pfizer, Novartis, Actelion, Boehringer Ingelheim.ATS has received speaker fees from Chiesi, Cipla, travel grants from Linde and VitalAire and in-kind equipment for the institution from Linde and Gongora.SJ, NS, DN, DI, CT declare no potential competing interests.The authors have not been financially rewarded for writing and have no competing interests directly related to this manuscript.The authors declare no non-financial competing interests.